Geneoscopy: Don Hardison

Feb 28, 2023

Don Hardison has been appointed to the board of directors of gastrointestinal disease diagnostics firm Geneoscopy after serving as a strategic advisor to the company for two years. He was president and CEO of Biotheranostics until it was acquired by Hologic in 2021. Before that, he was president, CEO, and director of Good Start Genetics, and prior to that, he was president and CEO of Exact Sciences.

Breaking News

WHO Approves Abbott Molecular Mpox Assay
Foresight Diagnostics Founders Respond to Roche Lawsuit, Says Claims Asserted in Bad Faith
Participant Health Privacy at Risk From Single-Cell RNA Sequencing Data, Study Suggests
With $40M in Funding, Cancer AI Alliance Aims to Pool Data, Computing Resources to Boost Research
Oncocyte Nets $10.2M in Private Placement, Notes New Customers for Transplant Test

Geneoscopy: Don Hardison

WHO Approves Abbott Molecular Mpox Assay

Foresight Diagnostics Founders Respond to Roche Lawsuit, Says Claims Asserted in Bad Faith

Participant Health Privacy at Risk From Single-Cell RNA Sequencing Data, Study Suggests

With $40M in Funding, Cancer AI Alliance Aims to Pool Data, Computing Resources to Boost Research

Oncocyte Nets $10.2M in Private Placement, Notes New Customers for Transplant Test